WRI 2005

In its fourth consecutive year, the Women and HIV Think Tank officially changed its name to the "Women's Research Initiative on HIV/AIDS (WRI)"  in 2005 to accurately reflect the real work of this group, to convey our ongoing commitment to tangible and measurable results in the management of HIV disease in women, and to establish TWP's role in providing sustained leadership for this effort. The most significant outcome of the 2005 meeting is the unequivocal consensus that emerged that increasing the participation of women in research is the most tangible mechanism for improving HIV treatment and prevention efforts for all women over the long term. Participants elected to form three working groups to pursue initiatives in 2006:

  1. Standards of Treatment and Care
  2. Policy Agenda
  3. Community Engagement

The 2005 Think Tank included thirty of the nearly sixty individuals involved in this initiative. Following our multidisciplinary focus, the participants represented research institutions, clinics, government agencies, advocacy organizations, and pharmaceutical companies. A list of the 2005 meeting participants can be found below.

For the full 2005 meeting report and a detailed action plan of the working groups, please click below.

2005 WRI Meeting Participants

Judith D. Auerbach, PhD 
Vice President, Public Policy and Program Development
amfAR
Dawn Averitt Bridge 
Founder
The Well Project
Gina Brown, MD 
Medical Director
Cicatelli Associates, Inc.
Susan Ellen Cohn, MD, MPH 
Associate Professor of Medicine
University of Rochester
Jenna Conley 
Senior Manager
Gilead Sciences
Robert W. Coombs, MD, PhD, FRCPC 
Professor, Laboratory Medicine
University of Washington
Terri Creagh, PhD 
Clinical and Epidemiologic Research
Ron Falcon, MD 
Medical Director, Virology
Tibotec Therapeutics
Judith Feinberg, MD 
Professor of Medicine
University of Cincinnati
Becky Griesse 
Research Assistant
Forum for Collaborative HIV Research
Jane Hitti, MD 
University of Washington Medical Center
Beri Hull 
Global Advocacy Officer: Access to Care, Treatment and Support
The International Community of Women Living with HIV and AIDS (ICW)
Ben Kozub 
Product Manager, HIV
Boehringer Ingelheim Pharmaceuticals
Sharon Lee, MD 
Director
Family Health Center
Heidi Nass 
Coordinator, Treatment Support and Education Program
HIV Care Program, University of Wisconsin Hospital and Clinics
Nancy Norman, MD, MPH 
Medical Director
Boston Public Health Commission
Cathy Olufs 
Education Director
CorrectHELP - The Corrections HIV Education and Law Project
Nancy Padian, PhD 
Professor
UCSF
Andrew Pavia, MD 
University of Utah
Kristy D. Porter, PharmD 
Associate Director, Virology Medical Affairs
Bristol-Myers Squibb
Tonia Poteat, PA-C 
Grady Infectious Disease Program
Patricia Reichelderfer, PhD 
Microbiologist
NIH/NICHD
Star Seyedkazemi, PharmD 
Clinical Science Manager, Abbott Virology
Abbott Laboratories
Kathleen E. Squires, MD 
Director, Division of Infectious Diseases
Thomas Jefferson University
Stephen Storfer, MD 
Associate Director, Virology
Clinical and Scientific Affairs
Boehringer Ingelheim Pharmaceuticals, Inc.
Melanie Thompson, MD 
Principal Investigator
AIDS Research Consortium of Atlanta
Fulvia Veronese, PhD 
Health Science Administrator
NIH, Office of AIDS Research
Etiology and Pathogenesis and Microbicide Section
 

Meeting Staff 

Megan Raspa
Project Manager
The Well Project

Facilitators

Richard Averitt 
Chief Operating Officer
The Well Project

Ron Wilder 
President
Aligned Action, Inc.

Meeting Planners 

Debbie Cooke 
VP, Chief Operations Officer
Meeting Masters, Inc. 

Tina DeRenzis 
President
Meeting Masters, Inc.

Do you get our newsletter?

admin's picture

Sign up for our monthly Newsletter and get the latest info in your inbox.

seventh name

There are several different options for reducing the chances of passing on HIV while trying to get pregnant. If you are a man living with HIV and an HIV-negative woman seeking information on getting pregnant, the options below will help you understand what might be the best for you, and to prepare for discussions with your health care provider.

Injection drug users are at high risk of HIV and hepatitis. Learn how to reduce your risk of infection, including how to clean drug equipment.

The 2003 Women and HIV Think Tank meeting was the first of its kind convened by The Well Project.

admin's picture

Join our community

Connect to our support community and share experiences with other women living with HIV.

Join now >

admin's picture

You Can Help!

Together, we can change the course of the HIV epidemic…one woman at a time!

Please donate now!>